FDCP
ELV icon

Foster Dykema Cabot & Partners’s Elevance Health ELV Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56
Closed -$18.1K – 360
2025
Q3 		$18.1K Hold
56
– – ﹤0.01% 309
2025
Q2 		$21.8K Hold
56
– – ﹤0.01% 246
2025
Q1 		$24.4K Hold
56
– – ﹤0.01% 234
2024
Q4 		$20.7K Sell
56
-3
-5% -$1.25K ﹤0.01% 261
2024
Q3 		$30.7K Buy
+59
New +$31.5K ﹤0.01% 270

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Foster Dykema Cabot & Partners's ELV Position: Q4 2025 in Review

Foster Dykema Cabot & Partners sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 56 shares — an estimated $18.1K sold.

Foster Dykema Cabot & Partners first reported a position in ELV in Q3 2024 and held it in 5 quarters. The position peaked at $30.7K in Q3 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Foster Dykema Cabot & Partners reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Foster Dykema Cabot & Partners sold 56 Elevance Health shares in Q4 2025, an estimated $18.1K.
  • Foster Dykema Cabot & Partners first reported a position in Elevance Health in Q3 2024 and held it in 5 quarters.
  • Foster Dykema Cabot & Partners's Elevance Health position peaked at $30.7K in Q3 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.